(Q43663314)

25 November 2017

title

Combretastatin A-4 and hyperthermia;a potent combination for the treatment of solid tumors (English)

1 reference

25 November 2017

3

Mella O

1 reference

25 November 2017

4

Dahl O

1 reference

25 November 2017

2

Bjerkvig R

1 reference

25 November 2017

1

Eikesdal HP

1 reference

25 November 2017

language of work or name

1 reference

1 August 2001

1 reference

Radiotherapy and Oncology

25 November 2017

published in

1 reference

25 November 2017

volume

60

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

147-154

1 reference

Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Effect of Hyperthermia on a Neurogenic Rat Cell Line (BT4A) in Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Midazolam and fentanyl-fluanisone: assessment of anaesthetic effects in laboratory rodents and rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Vinca alkaloids: anti-vascular effects in a murine tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Stromal sensitivity to radiation and hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Use of the vasodilator sodium nitroprusside during local hyperthermia: effects on tumor temperature and tumor response in a rat tumor model.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Endothelial injury caused by antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

A cerebral glioma model for experimental therapy and in vivo invasion studies in syngeneic BD IX rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Blood flow in human tumors during hyperthermia therapy: demonstration of vasoregulation and an applicable physiological model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Use of nitroprusside to increase tissue temperature during local hyperthermia in normal and tumor-bearing dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Regional blood flow by fractional distribution of indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Distribution of cardiac output during pentobarbital versus midazolam/fentanyl/fluanisone anaesthesia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900318-2

7 January 2021

10.1016/S0167-8140(00)00318-2

Identifiers

DOI

1 reference

25 November 2017

1 reference